Cart
sales@molnova.com
Home - Products - Others - Other Targets - (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P

(D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P

CAS No. 115760-58-2

(D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P( ——— )

Catalog No. M40446 CAS No. 115760-58-2

(D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P is a selective NK1 receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P
  • Note
    Research use only, not for human use.
  • Brief Description
    (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P is a selective NK1 receptor antagonist.
  • Description
    (D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P is a selective NK1 receptor antagonist.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    NK1
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    115760-58-2
  • Formula Weight
    1427.75
  • Molecular Formula
    C67H102N20O13S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hicks RP. Recent advances in NMR: expanding its role in rational drug design. Curr Med Chem. 2001 May;8(6):627-50.?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • GSK2879552 dihydroch...

    GSK2879552 dihydrochloride an orally active, selective and irreversible inhibitor of lysine specific demethylase 1 (LSD1/KDM1A), with potential antineoplastic activity.

  • PF-06446846 hydrochl...

    PF-06446846 hydrochloride, an orally active and highly selective inhibitor, targets Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) translation by inducing ribosomal stalling at approximately codon 34, effectively suppressing PCSK9 expression.

  • Lefradafiban

    Lefradafiban（BIBU-104） is an oral platelet glycoprotein IIb/IIIa receptor antagonist for the study of angina pectoris and acute coronary syndromes.

Sign In Join Free